SSY Group Limited

HKSE 2005.HK

SSY Group Limited Price to Sales Ratio (P/S) on January 27, 2025: 1.45

SSY Group Limited Price to Sales Ratio (P/S) is 1.45 on January 27, 2025, a -29.62% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

SSY Group Limited 52-week high Price to Sales Ratio (P/S) is 2.35 on March 28, 2024, which is 62.66% above the current Price to Sales Ratio (P/S).
SSY Group Limited 52-week low Price to Sales Ratio (P/S) is 1.41 on January 23, 2025, which is -2.81% below the current Price to Sales Ratio (P/S).
SSY Group Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 1.89.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

HKSE: 2005.HK

SSY Group Limited

CEO	Mr. Jiguang Qu
IPO Date	Dec. 20, 2005
Location	Hong Kong
Headquarters	Central Plaza
Employees	5,800
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Containers & Packaging Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Plastics

Description

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.

Key trends

Past 5 years